Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lomas

Showing results (91-100 of 282) with videos related to

Pageof 29
Sort By:
Thrombosis and Haemostasis|February 6, 2010
Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsetsGanesh Munuswamy-Ramanujam, Erbin Dai, Liying Liu, et al.
Bioscience Reports|May 11, 2013
Reactive centre loop mutants of α-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathwayImran Haq, James A Irving, Sarah V Faull, et al.
The FEBS Journal|January 8, 2025
Identification of an exosite at the neutrophil elastase/alpha-1-antitrypsin interfaceRoberto Gangemi, Mattia Bignotti, Andrea Denardo, et al.
International Journal of Molecular Sciences|June 2, 2021
The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency VariantRiccardo Ronzoni, Ilaria Ferrarotti, Emanuela D'Acunto, et al.
The FEBS Journal|May 18, 2006
Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosisLynda K Sharp, Meera Mallya, Kerri J Kinghorn, et al.
The Biochemical Journal|March 5, 2015
An antibody raised against a pathogenic serpin variant induces mutant-like behaviour in the wild-type proteinJames A Irving, Elena Miranda, Imran Haq, et al.
Journal of Clinical Pharmacology|November 18, 2011
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary diseaseDavid A Lomas, David A Lipson, Bruce E Miller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2016
Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary DiseaseMaggie Tabberer, Sebastian Gonzalez-McQuire, Hana Muellerova, et al.
Nature Reviews. Disease Primers|July 29, 2016
α1-Antitrypsin deficiencyCatherine M Greene, Stefan J Marciniak, Jeffrey Teckman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2010
Defining the mechanism of polymerization in the serpinopathiesUgo I Ekeowa, Joanna Freeke, Elena Miranda, et al.
Pageof 29

Showing results (91-100 of 282) with videos related to

Sort By:
Pageof 29
Thrombosis and Haemostasis|February 6, 2010
Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsetsGanesh Munuswamy-Ramanujam, Erbin Dai, Liying Liu, et al.
Bioscience Reports|May 11, 2013
Reactive centre loop mutants of α-1-antitrypsin reveal position-specific effects on intermediate formation along the polymerization pathwayImran Haq, James A Irving, Sarah V Faull, et al.
The FEBS Journal|January 8, 2025
Identification of an exosite at the neutrophil elastase/alpha-1-antitrypsin interfaceRoberto Gangemi, Mattia Bignotti, Andrea Denardo, et al.
International Journal of Molecular Sciences|June 2, 2021
The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency VariantRiccardo Ronzoni, Ilaria Ferrarotti, Emanuela D'Acunto, et al.
The FEBS Journal|May 18, 2006
Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosisLynda K Sharp, Meera Mallya, Kerri J Kinghorn, et al.
The Biochemical Journal|March 5, 2015
An antibody raised against a pathogenic serpin variant induces mutant-like behaviour in the wild-type proteinJames A Irving, Elena Miranda, Imran Haq, et al.
Journal of Clinical Pharmacology|November 18, 2011
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary diseaseDavid A Lomas, David A Lipson, Bruce E Miller, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 4, 2016
Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary DiseaseMaggie Tabberer, Sebastian Gonzalez-McQuire, Hana Muellerova, et al.
Nature Reviews. Disease Primers|July 29, 2016
α1-Antitrypsin deficiencyCatherine M Greene, Stefan J Marciniak, Jeffrey Teckman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2010
Defining the mechanism of polymerization in the serpinopathiesUgo I Ekeowa, Joanna Freeke, Elena Miranda, et al.
Pageof 29